Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease

PLoS Neglected Tropical Diseases

Volumn 2, Issue 7, 2008, Pages

  Skwor, Troy A ^a   Atik, Berna ^a   Kandel, Raj Prasad ^b   Adhikarl, Him Kant ^b   Sharma, Bassant ^b   Dean, Deborah ^a,b,c,d,e  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b Lumbini Rana Ambika Eye Hospital   (Nepal)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR; EOTAXIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VACCINE;

ADULT; AGED; ARTICLE; BLINDNESS; CHILD; CHLAMYDIA TRACHOMATIS; CONJUNCTIVA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DRUG DESIGN; ENDEMIC DISEASE; FEMALE; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RECURRENT INFECTION; TRACHOMA; TREATMENT WITHDRAWAL; WORLD HEALTH ORGANIZATION; ADOLESCENT; CROSS-SECTIONAL STUDY; DISEASE COURSE; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MUCOSA; NEPAL; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHEMOKINES; CHILD; CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; CONJUNCTIVA; CROSS-SECTIONAL STUDIES; CYTOKINES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEPAL; TRACHOMA; YOUNG ADULT;

EID: 56149116901     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000264     Document Type: Article

References (61)

1. Dean D (1997) Chlamydial Infections. In: Conner D, ed. Pathology of Infectious Diseases: Appleton and Lange. pp 473-507.
2. Dawson CR, Schachter J (1985) Strategies for treatment and control of blinding trachoma: cost-effectiveness of topical or systemic antibiotics. Rev Infect Dis 7: 768-773.
3. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73: 115-121.
4. Gerbase AC, Rowley JT, Mertens TE (1998) Global epidemiology of sexually transmitted diseases. Lancet 351 Suppl 3: 2-4.
5. Schumacher HR Jr, Magge S, Cherian PV, Sleckman J, Rothfuss S, et al. (1988) Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease. Arthritis Rheum 31: 937-946.
6. Neuer A, Lam KN, Tiller FW, Kiesel L, Witkin SS (1997) Humoral immune response to membrane components of Chlamydia trachomatis and expression of human 60 kDa heat shock protein in follicular fluid of in-vitro fertilization patients. Hum Reprod 12: 925-929.
7. Frick KD, Basilion EV, Hanson CL, Colchero MA (2003) Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiol 10: 121-132.
8. Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, et al. (2004) Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 292: 721-725.
9. Atik B, Thanh TT, Luong VQ, Lagree S, Dean D (2006) Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. Jama 296: 1488-1497.
10. Zhang H, Kandel RP, Sharma B, Dean D (2004) Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention. Arch Ophthalmol 122: 511-516.
11. West ES, Mkocha H, Munoz B, Mabey D, Foster A, et al. (2005) Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci 46: 447-453.
12. West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, et al. (2005) Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366: 1296-1300.
13. Broman AT, Shum K, Munoz B, Duncan DD, West SK (2006) Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Invest Ophthalmol Vis Sci 47: 99-104.
14. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR (1987) A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65: 477-483.
15. Yoneda C, Dawson CR, Daghfous T, Hoshiwara I, Jones P, et al. (1975) Cytology as a guide to the presence of chlamydial inclusions in Giemsa-stained conjunctival smears in severe endemic trachoma. Br J Ophthalmol 59: 116-124.
16. el-Asrar AM, Van den Oord JJ, Geboes K, Missotten L, Emarah MH, et al. (1989) Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol 73: 276-282.
17. Whittum-Hudson JA, Taylor HR, Farazdaghi M, Prendergast RA (1986) Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. Invest Ophthalmol Vis Sci 27: 64-69.
18. Patton DL, Taylor HR (1986) The histopathology of experimental trachoma: ultrastructural changes in the conjunctival epithelium. J Infect Dis 153: 870-878.
19. Bobo L, Novak N, Mkocha H, Vitale S, West S, et al. (1996) Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun 64: 3273-3279.
20. Faal N, Bailey RL, Sarr I, Joof H, Mabey DC, et al. (2005) Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection. Clin Exp Immunol 142: 347-353.
21. Burton MJ, Bailey RL, Jeffries D, Mabey DC, Holland MJ (2004) Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun 72: 7352-7356.
22. Faal N, Bailey RL, Jeffries D, Joof H, Sarr I, et al. (2006) Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection? PLoS Med 3: e266. doi:10.1371/journal. pmed.0030266.
23. Young E, Taylor HR (1984) Immune mechanisms in chlamydial eye infection: cellular immune responses in chronic and acute disease. J Infect Dis 150: 745-751.
24. Bailey RL, Holland MJ, Whittle HC, Mabey DC (1995) Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect Immun 63: 389-392.
25. Holland MJ, Bailey RL, Hayes LJ, Whittle HC, Mabey DC (1993) Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J Infect Dis 168: 1528-1531.
26. Young E, Taylor HR (1986) Immune mechanisms in chlamydial eye infection. Development of T suppressor cells. Invest Ophthalmol Vis Sci 27: 615-619.
27. Fernandez MC, Walters J, Marucha P (1996) Transcriptional and post-transcriptional regulation of GM-CSF-induced IL-1 beta gene expression in PMN. J Leukoc Biol 59: 598-603.
28. Turner M, Chantry D, Buchan G, Barrett K, Feldmann M (1989) Regulation of expression of human IL-1 alpha and IL-1 beta genes. J Immunol 143: 3556-3561.
29. Fan J, Heller NM, Gorospe M, Atasoy U, Stellato C (2005) The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. Eur Respir J 26: 933-947.
30. Bamford RN, Battiata AP, Waldmann TA (1996) IL-15: the role of translational regulation in their expression. J Leukoc Biol 59: 476-480.
31. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OS, et al. (1997) Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 65: 1003-1006.
32. Hessel T, Dhital SP, Plank R, Dean D (2001) Immune response to chlamydial 60-kilodalton heat shock protein in tears from Nepali trachoma patients. Infect Immun 69: 4996-5000.
33. Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Ther 8 Suppl 2: S3.
34. Luster AD (1998) Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436-445.
35. Budagian V, Bulanova E, Paus R, Bulfone-Paus S (2006) IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev 17: 259-280.
36. Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF (2007) The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 48: 751-762.
37. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328: 106-113.
38. Hvid M, Baczynska A, Deleuran B, Fedder J, Knudsen HJ, et al. (2007) Interleukin-1 is the initiator of fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol.
39. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL (1997) Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun 65: 2175-2182.
40. Williams DM, Grubbs BG, Darville T, Kelly K, Rank RG (1998) A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect Immun 66: 4564-4567.
41. Perry LL, Feilzer K, Caldwell HD (1998) Neither interleukin-6 nor inducible nitric oxide synthase is required for clearance of Chlamydia trachomatis from the murine genital tract epithelium. Infect Immun 66: 1265-1269.
42. Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, et al. (2003) Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 171: 6187-6197.
43. Wang C, Tang J, Crowley-Nowick PA, Wilson CM, Kaslow RA, et al. (2005) Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents. Clin Exp Immunol 142: 548-554.
44. Seo N, Hayakawa S, Takigawa M, Tokura Y (2001) Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity. Immunology 103: 449-457.
45. Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, et al. (2006) Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J Exp Med 203: 1021-1031.
46. Munn DH, Mellor AL (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117: 1147-1154.
47. van der Sluijs KF, Nijhuis M, Levels JH, Florquin S, Mellor AL, et al. (2006) Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis 193: 214-222.
48. Marks E, Verolin M, Stensson A, Lycke N (2007) Differential CD28 and Inducible Costimulatory Molecule Signaling Requirements for Protective CD4+ T-Cell-Mediated Immunity against Genital Tract Chlamydia trachomatis Infection. Infect Immun 75: 4638-4647.
49. Reddy BS, Rastogi S, Das B, Salhan S, Verma S, et al. (2004) Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses. Clin Exp Immunol 137: 552-558.
50. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, et al. (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191: 771-780.
51. Picker LJ, Reed-Inderbitzin EF, Hagen SI, Edgar JB, Hansen SG, et al. (2006) IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J Clin Invest 116: 1514-1524.
52. Biancotto A, Grivel JC, Iglehart SJ, Vanpouille C, Lisco A, et al. (2007) Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109: 4272-4279.
53. Yoshihara K, Yajima T, Kubo C, Yoshikai Y (2006) Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 55: 334-341.
54. Gerard HC, Wang Z, Whittum-Hudson JA, El-Gabalawy H, Goldbach-Mansky R, et al. (2002) Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol 29: 1827-1835.
55. Whittum-Hudson JA, Prendergast RA, Taylor HR (1986) Changes in conjunctival lymphocyte populations induced by oral immunization with Chlamydia trachomatis. Curr Eye Res 5: 973-979.
56. Sato N, Patel HJ, Waldmann TA, Tagaya Y (2007) The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc Natl Acad Sci U S A 104: 588-593.
57. Clark RA, Kupper TS (2007) IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 109: 194-202.
58. Yong EC, Klebanoff SJ, Kuo CC (1982) Toxic effect of human polymorphonuclear leukocytes on Chlamydia trachomatis. Infect Immun 37: 422-426.
59. Darville T, Andrews CW Jr, Sikes JD, Fraley PL, Rank RG (2001) Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect Immun 69: 3556-3561.
60. Darville T, Andrews CW Jr, Sikes JD, Fraley PL, Braswell L, et al. (2001) Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response. Infect Immun 69: 7419-7424.
61. Maxion HK, Kelly KA (2002) Chemokine expression patterns differ within anatomically distinct regions of the genital tract during Chlamydia trachomatis infection. Infect Immun 70: 1538-1546.